-+ 0.00%
-+ 0.00%
-+ 0.00%

BioMarin EVP, Chief R&D Officer Gregory R Friberg Reports Sale of $302,710.511 in Common Shares

PUBT·11/19/2026 23:05:01
Listen to the news
BioMarin EVP, Chief R&D Officer Gregory R Friberg Reports Sale of $302,710.511 in Common Shares
  • BioMarin Pharmaceutical EVP and Chief R&D Officer Gregory R. Friberg sold 5,147 common shares on Nov. 18, 2026.
  • The sale price was $58.813 per share, leaving direct holdings of 42,585 shares.
  • The Form 4 was dated Nov. 19, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMarin Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-075143), on November 19, 2026, and is solely responsible for the information contained therein.